AAAAAA

   
Results: 1-21 |
Results: 21
Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients: A phase II study
Authors: Nole, F Munzone, E Mandala, M Catania, C Orlando, L Zampino, MG Minchella, I Colleoni, M Peruzzotti, G Marrocco, E Goldhirsch, A
Citation: F. Nole et al., Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients: A phase II study, ANN ONCOL, 12(1), 2001, pp. 95-100
Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulatingdendritic cells, IL-12 and endothelin-1
Authors: Lissoni, P Malugani, F Bonfanti, A Bucovec, R Secondino, S Brivio, F Ferrari-Bravo, A Ferrante, R Vigore, L Rovelli, F Mandala, M Viviani, S Fumagalli, L Gardani, GS
Citation: P. Lissoni et al., Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulatingdendritic cells, IL-12 and endothelin-1, J BIOL REG, 15(2), 2001, pp. 140-144
Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients
Authors: Mandala, M Moro, C Ferretti, G Calabro, MG Nole, F Rocca, A Munzone, E Castro, A Curigliano, G
Citation: M. Mandala et al., Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients, ANTICANC R, 21(1B), 2001, pp. 585-588
Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine
Authors: De Pas, T de Braud, F Mandala, M Curigliano, G Catania, C Ferretti, G Sozzi, P Solli, P Goldhirsch, A
Citation: T. De Pas et al., Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine, LUNG CANC, 31(2-3), 2001, pp. 267-270
Progress report on the palliative therapy of 100 patients with neoplastic effusions by intracavitary low-dose interleukin-2
Authors: Lissoni, P Mandala, M Curigliano, G Ferretti, G Moro, C Ardizzoia, A Malugani, F Tancini, G Tisi, E Arrigoni, C Barni, S
Citation: P. Lissoni et al., Progress report on the palliative therapy of 100 patients with neoplastic effusions by intracavitary low-dose interleukin-2, ONCOL-BASEL, 60(4), 2001, pp. 308-312
Unexpected right phrenic nerve injury during 5-fluorouracil continuous infusion plus cisplatin and vinorelbine in breast cancer patients
Authors: Munzone, E Nole, F Orlando, L Mandala, M Biffi, R Ciano, C Villa, G Civelli, M Goldhirsch, A
Citation: E. Munzone et al., Unexpected right phrenic nerve injury during 5-fluorouracil continuous infusion plus cisplatin and vinorelbine in breast cancer patients, J NAT CANC, 92(9), 2000, pp. 755-755
Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer
Authors: Ferretti, G Curigliano, G Pastorino, U Cittadini, A Flamini, G Calabro, MG De Pas, T Orlando, L Mandala, M Colleoni, M Spaggiari, L Granone, PL Pagliari, G de Braud, F Fazio, N Goldhirsch, A
Citation: G. Ferretti et al., Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer, CLIN CANC R, 6(6), 2000, pp. 2393-2400
Abrogation of the negative influence of opioids on IL-2 immunotherapy of renal cell cancer by melatonin
Authors: Lissoni, P Mandala, M Brivio, F
Citation: P. Lissoni et al., Abrogation of the negative influence of opioids on IL-2 immunotherapy of renal cell cancer by melatonin, EUR UROL, 38(1), 2000, pp. 115-118
Paradoxical stimulation of prolactin secretion by L-dopa in metastatic prostate cancer and its possible role in prostate-cancer-related hyperprolactinemia
Authors: Lissoni, P Mandala, M Rovelli, F Casu, M Rocco, F Tancini, G Scardino, E
Citation: P. Lissoni et al., Paradoxical stimulation of prolactin secretion by L-dopa in metastatic prostate cancer and its possible role in prostate-cancer-related hyperprolactinemia, EUR UROL, 37(5), 2000, pp. 569-572
Depression and degree of acceptance of adjuvant cytotoxic drugs
Authors: Colleoni, M Mandala, M Peruzzotti, G Robertson, C Bredart, A Goldhirsch, A
Citation: M. Colleoni et al., Depression and degree of acceptance of adjuvant cytotoxic drugs, LANCET, 356(9238), 2000, pp. 1326-1327
Five-year survival results of subcutaneous low-dose immunotherapy with interleukin-2 alone in metastatic renal cell cancer patients
Authors: Bordin, V Giani, L Meregalli, S Bukovec, R Vaghi, MM Mandala, M Paolorossi, F Ardizzoia, A Tancini, G Barni, S Frigerio, F Fumagalli, L Bordoni, A Valusani, G Di Felice, G Lissoni, P
Citation: V. Bordin et al., Five-year survival results of subcutaneous low-dose immunotherapy with interleukin-2 alone in metastatic renal cell cancer patients, UROL INTERN, 64(1), 2000, pp. 3-8
Acute vulvar vestibulitis occurring during chemotherapy with cryptophycin analogue LY355703
Authors: De Pas, TM Mandala, M Curigliano, G Peccatori, F
Citation: Tm. De Pas et al., Acute vulvar vestibulitis occurring during chemotherapy with cryptophycin analogue LY355703, OBSTET GYN, 95(6), 2000, pp. 1030-1030
Decreased toxicity and increased efficacy of cancer chemotherapy using thepineal hormone melatonin in metastatic solid tumour patients with poor clinical status
Authors: Lissoni, P Barni, S Mandala, M Ardizzoia, A Paolorossi, F Vaghi, M Longarini, R Malugani, F Tancini, G
Citation: P. Lissoni et al., Decreased toxicity and increased efficacy of cancer chemotherapy using thepineal hormone melatonin in metastatic solid tumour patients with poor clinical status, EUR J CANC, 35(12), 1999, pp. 1688-1692
Awareness of disease among Italian cancer patients: Is there a need for further improvement in patient information?
Authors: Ruggeri, B Ballatori, E Casali, P Tamburini, M Licitra, L Mencaglia, E Roila, F Cortesi, E Massidda, B Costantini, M De Angelis, V Ciccarese, G Mattei, A Valori, VM Lelli, G Nanni, L Romano, MP Di Maggio, G Morritti, MG Di Micco, C Palladino, MA Porrozzi, S De Angelis, V Ciccarese, G Milella, G Bruno, ML Basurto, C Locatelli, MC Valsecchi, R Zamparelli, G Pessi, A Molaro, O Luporini, G Giovanni, S Bertetto, O Donadio, M Fanchini, L Mistrangelo, M Bumma, C Parello, G Malacarne, P Donati, D Scapoli, D Ferrari, A Olmi, P Galardi, A Panichi, M Ruggiero, C Zironi, S Banzi, C Piccinini, L Campora, E Venturino, A Vincenti, M Gasco, M Marchioro, G Barbato, F Azzarello, G Vinante, O Sabbioni, R Nortilli, R Griso, C Cetto, L Aste, MG Pasqualucci, S Chierchi, MC Floris, C Barbieri, E Frezza, G Bunkeila, F Bonci, F Sarobba, MG Farris, A Sanna, G Ionta, MT Murru, R Mascia, MG Lopez, M Amodio, A Paoletti, G Timio, L Romano, M Amichetti, M Barni, S Ardizzoia, A Mandala, M Maxia, G Dessi, M Acito, L Giustini, L Casarini, MB Smerieri, F Riva, N Maltoni, M Antimi, M Bellini, V Boz, G Brema, F De Candis, D Polico, C Mandoliti, G Amendola, P Iacono, C Imperato, A Gelmi, S Giovanni, S Maluta, S Selvestrel, C Cognetti, F Barduagni, M Fusco, V Rossi, M Bracci, R Antognoli, S Mascia, V Farci, D Vitale, V Musi, M Grasso, F Nicodemo, M Cirillo, M Botta, M De Giovanni, D Giuliodori, L Silva, RR Martignetti, A Deplacido, S Domini, P Gareri, R Porcile, G Dalla Mola, A Ambrosini, G Casi, C Del Favero, A Pignata, S Ricchi, P Folco, U Castellana, MA Salvi, G Lionello, R Gaion, F Ronco, M Troccoli, G Ranuzzi, M Marchetti, P Montinari, F Fioretto, L Palmeri, S Sassi, M Carreca, I Cinieri, S Graiff, C Cariello, S Mantovani, G Lazzaro, B Spada, S Rosati, G De Marinis, F Gravina, A La Ciura, P Ognibeni, M Iannone, T Pusceddu, G Buffoli, A Marcellini, M
Citation: B. Ruggeri et al., Awareness of disease among Italian cancer patients: Is there a need for further improvement in patient information?, ANN ONCOL, 10(9), 1999, pp. 1095-1100
Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: A phase II study
Authors: Lissoni, P Tancini, G Paolorossi, F Mandala, M Ardizzoia, A Malugani, F Giani, L Barni, S
Citation: P. Lissoni et al., Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: A phase II study, J PINEAL R, 26(3), 1999, pp. 169-173
Circulating dendritic cells in early and advanced cancer patients: diminished percent in the metastatic disease
Authors: Lissoni, P Vigore, L Ferranti, R Bukovec, R Meregalli, S Mandala, M Barni, S Tancini, G Fumagalli, L Giani, L
Citation: P. Lissoni et al., Circulating dendritic cells in early and advanced cancer patients: diminished percent in the metastatic disease, J BIOL REG, 13(4), 1999, pp. 216-219
Endocrinological study of the dopaminergic regulation of prolactin releasein metastatic breast cancer
Authors: Mandala, M Lissoni, P Ardizzoia, A Barni, S Rovelli, F Confalonieri, G Malugani, F Moro, C Fumagalli, G Giani, L Tancini, G
Citation: M. Mandala et al., Endocrinological study of the dopaminergic regulation of prolactin releasein metastatic breast cancer, TUMORI, 85(6), 1999, pp. 494-497
Patient compliance with quality of life questionnaires
Authors: Roila, F Ballatori, E Mattei, A Cortesi, E Tamburini, M Casali, P Licitra, L Mencaglia, E Costantini, M Massidda, B De Angelis, V Ciccarese, G Valori, VM Lelli, G Nanni, L Romano, MP Di Maggio, G Morritti, MG Di Micco, C Palladino, MA Porrozzi, S Milella, G Locatelli, MC Valsecchi, V Zamparelli, G Pessi, A Molaro, O Luporini, G Bertetto, O Donadio, M Fanchini, L Mistrangelo, M Bumma, C Parello, G Malacarne, P Donati, D Scapoli, D Ferrari, A Olmi, P Galardi, A Panichi, M Ruggiero, C Zironi, S Banzi, C Piccinini, L Campora, E Venturino, A Vincenti, M Gasco, M Marchioro, G Barbato, F Azzarello, G Vinante, O Sabbioni, R Nortilli, R Griso, C Cetto, L Aste, MG Pasqualucci, S Chierchi, MC Floris, C Barbieri, E Frezza, G Bunkeila, F Bonci, F Sarobba, MG Farris, A Sanna, G Ionta, MT Murru, R Mascia, MG Lopez, M Amodio, A Paoletti, G Tomio, L Romano, M Amichetti, M Barni, S Ardizzoia, A Mandala, M Maxia, G Dessi, M Acito, L Giustini, L Casarini, MB Smerieri, F Riva, N Maltoni, M Antimi, M Bellini, V Boz, G Brema, F Mencaglia, E De Candis, D Polico, C Mandoliti, G Amendola, P Iacono, C Imperato, A Gelmi, S Maluta, S Selvestrel, C Giovanni, S Cognetti, F Barduagni, M Fusco, V Pozzi, G Bracci, R Antognoli, S Mascia, V Farci, D Vitale, V Musi, M Grasso, F Nicodemo, M Cirillo, M Botta, M De Giovanni, D Giuliodori, L Silva, RR Martignetti, A Domini, P Gareri, R Porcile, G Dalla Mola, A Ambrosini, G Casi, C Del Favero, A Pignata, S Ricchi, P Folco, U Castellana, MA Salvi, G Lionello, R Gaion, F Ronco, M Troccoli, G Ranuzzi, M Marchetti, P Montinari, F Fioretto, L Palmeri, S Sassi, M Carreca, I Cinieri, S Graiff, C Cariello, S Mantovani, G Lazzaro, B Spada, S Rosati, G De Marinis, F Gravina, A La Ciura, P Ognibeni, M Iannone, T Pusceddu, G Buffoli, A Menichetti, ET
Citation: F. Roila et al., Patient compliance with quality of life questionnaires, TUMORI, 85(2), 1999, pp. 92-95
Negative influence of morphine on the efficacy of interleukin-2 cancer immunotherapy
Authors: Lissoni, P Mandala, M Giani, L Brivio, F Paolorossi, F Bordoni, A Fumagalli, L
Citation: P. Lissoni et al., Negative influence of morphine on the efficacy of interleukin-2 cancer immunotherapy, INT J IMM T, 15(1), 1999, pp. 31-34
Neuroimmunotherapy with subcutaneous low-dose interleukin-2 plus the pineal oncostatic hormones melatonin and 5-methoxytryptamine in untreatable advanced solid neoplasm patients with very poor clinical status
Authors: Lissoni, P Mandala, M Mandelli, A Fumagalli, L
Citation: P. Lissoni et al., Neuroimmunotherapy with subcutaneous low-dose interleukin-2 plus the pineal oncostatic hormones melatonin and 5-methoxytryptamine in untreatable advanced solid neoplasm patients with very poor clinical status, INT J IMM T, 15(1), 1999, pp. 35-38
The fluorescent cationic dye rhodamine 6G as a probe for membrane potential in bovine aortic endothelial cells
Authors: Mandala, M Serck-Hanssen, G Martino, G Helle, KB
Citation: M. Mandala et al., The fluorescent cationic dye rhodamine 6G as a probe for membrane potential in bovine aortic endothelial cells, ANALYT BIOC, 274(1), 1999, pp. 1-6
Risultati: 1-21 |